Table 1.
Baseline characteristics of the included patients (n=24) prior to the start of mitotane.
| Age at diagnosis (years) | 52.5 (42.8-58) | |
| BMI (kg/m2) | 24.5 (22-25.8) | |
| Smoking habit | Current smokers | 3 (12.5%) |
| Past smokers | 9 (37.5%) | |
| Alcohol habit | Regular drinkers | 7 (29.2%) |
| Occasional drinkers | 5 (20.8%) | |
| ACC side (left) | 15 (62.5%) | |
| ACC secretion | Non-secreting ACC | 14 (58.3%) |
| Only cortisol | 5 (20.8%) | |
| Cortisol + adrenal androgens | 2 (8.3%) | |
| Cortisol + aldosterone | 1 (4.2%) | |
| Cortisol + estrogens | 1 (4.2%) | |
| Only estrogens | 1 (4.2%) | |
| Metastatic ACC | 15 (62.5%) | |
| Hypogonadism | 10 (41.7%) | |
Data are expressed as median (IQR) for continuous variables and as absolute number (%) for categorical variables. IQR, interquartile range; BMI, Body Mass Index; ACC, adrenocortical carcinoma.